In high-stakes industries—pharmaceuticals, biotechnology, medical devices, and specialty chemicals—quality is not a luxury. It is a legal and ethical requirement. One of the most powerful tools to ensure consistent quality across your supply chain is the Certificate of Analysis (COA). Yet many purchasers and quality managers do not systematically request a COA for every single batch they receive. This oversight can lead to hidden risks, regulatory non-compliance, and costly recalls. Below, we examine why a per-batch COA request is essential, how to interpret it, and how it strengthens your quality management system.

A Certificate of Analysis is an official document issued by the manufacturer or supplier that confirms the results of testing performed on a specific batch (or lot) of a product. It lists the product name, batch number, manufacturing date, expiry date, specifications, test methods, and the actual results for each quality attribute. Critically, the COA shows whether the batch meets the predetermined acceptance criteria. Without a COA for each batch, you have no documented evidence that the material you received is identical in quality to the one you originally qualified.

The first reason to request a COA for every delivery is traceability. When a product moves through multiple supply chain nodes—from raw material supplier to contract manufacturer to final distribution—each batch can vary slightly due to changes in raw material sources, processing conditions, or environmental factors. A batch-specific COA provides a unique record that ties the test results directly to that exact unit. In the event of a quality deviation, you can quickly isolate which batches are affected and take corrective action. This traceability is mandatory under Good Manufacturing Practice (GMP) and ISO 9001:2015 standards.

Second, a COA per batch enables accurate incoming quality control. Instead of relying on a single qualification report that may be months or years old, you can compare the current batch’s test results against your own internal specifications or pharmacopoeial standards. For example, in pharmaceutical compounding, the United States Pharmacopeia (USP) requires that each active pharmaceutical ingredient (API) batch be tested for identity, purity, potency, and impurities. If your supplier’s COA shows that a particular batch is within 98-102% of label claim, you can confidently release it for production. If the results are borderline or outside spec, you can initiate a reject or request further investigation.

Third, regulatory bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and World Health Organization (WHO) inspect supply chains for documented evidence of quality assurance. During a pre-approval inspection or a routine GMP audit, an inspector will ask: “Show me the COA for the last three batches of your excipient.” If you cannot produce batch-specific COAs, you risk an observation (FDA Form 483) or a warning letter. Worse, if a batch fails later in the field and you have no COA record, the regulator may assume that you never verified the material, leading to enforcement actions including import alerts or product seizure.

However, simply receiving a COA is not enough. You must verify its authenticity. A recent trend—especially in global supply chains—is falsified or “ghost” COAs where suppliers copy a previous batch’s data without retesting. To combat this, adopt a systematic verification protocol: check that the batch number on the COA matches the batch number on the container; confirm that the test methods cited are current and valid; request the actual raw data (chromatograms, spectra) for critical attributes; and perform periodic in-house testing to cross-check a sample of COA results. Some advanced quality management software can even parse COAs automatically and flag discrepancies in potency, particle size, or residual solvents.

It is also important to define the scope of your COA request in your supplier quality agreement. Specify that a COA must accompany every batch, that it must be issued within a certain number of days after release, and that deviations from specifications must be reported immediately. If a supplier refuses to provide batch-specific COAs, consider that a red flag. Reliable suppliers understand that the COA is a core element of their service, not an optional extra.

From a cost-benefit perspective, the investment in verifying every batch COA is minor compared to the cost of a recall. A single pharmaceutical recall can cost millions of dollars in direct expenses—transportation, destruction, legal fees—plus incalculable reputational damage. Moreover, batch-level COA documentation can serve as a strong defense in litigation. If you are sued for a product defect, having all COAs on file proves that you exercised due diligence in evaluating the raw materials.

Finally, remember that the COA helps protect the patient. Every pharmaceutical product, every medical device, and every nutritional supplement is ultimately consumed by a person. The quality of that batch determines whether it will treat a condition effectively or cause harm. By demanding a Certificate of Analysis for every batch delivered, you stand as the guardian of that patient’s safety.

In summary, the process is simple: Require a COA in your purchase orders. Verify its contents. Store it in a retrievable system. Use it to make release decisions. And when you see a batch without a COA, stop the shipment. In a world where quality can mean the difference between health and harm, batch-level documentation is not a burden—it is a baseline. Start requesting per-batch COA today, and you will build a supply chain that is transparent, compliant, and trustworthy.